6 DIMENSIONS CAPITAL
6 Dimensions Capital was established in May, 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures. The two prominent and experienced teams formed a healthcare focused investment firm with an in-depth focus and extensive coverage both in China and global market.
6 DIMENSIONS CAPITAL
Industry:
Health Care Venture Capital
Founded:
2017-05-01
Status:
Active
Contact:
+86(21) 6839 1989
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon Font Awesome Microsoft Azure DNS GoDaddy DNS GoDaddy ThemePunch
Similar Organizations
Gilde Healthcare
Gilde Healthcare is a healthcare investor that does lower mid-market buyouts and later stage venture.
Jianxin Capital
Jianxin Capital is focused on healthcare industry risk investment fund.
Quan Capital
Quan Capital is a healthcare focused venture capital firm.
Current Employees Featured
Dr. Ge Li
Dr. Ge Li Founding Partner & Chairman @ 6 Dimensions Capital Founding Partner & Chairman
Robert M. Brenner
Robert M. Brenner Executive in Residence @ 6 Dimensions Capital Executive in Residence 2020-02-01
Edward Hu
Edward Hu Founding Partner @ 6 Dimensions Capital Founding Partner
Hannes Thor Smรกrason
Hannes Thor Smรกrason Venture Partner @ 6 Dimensions Capital Venture Partner
Wei Li
Wei Li Managing Partner @ 6 Dimensions Capital Managing Partner
Ching Zhu
Ching Zhu Managing Partner @ 6 Dimensions Capital Managing Partner
Lianyong Chen
Lianyong Chen Managing Partner and CEO @ 6 Dimensions Capital Managing Partner and CEO
Founder
Dr. Ge Li
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-11-11 | Ignis Therapeutics | 6 Dimensions Capital investment in Series A - Ignis Therapeutics | 180 M USD |
2021-10-05 | Exo Therapeutics | 6 Dimensions Capital investment in Series B - Exo Therapeutics | 78 M USD |
2021-05-26 | Engine Biosciences | 6 Dimensions Capital investment in Series A - Engine Biosciences | 43 M USD |
2021-01-25 | TScan Therapeutics | 6 Dimensions Capital investment in Series C - TScan Therapeutics | 100 M USD |
2021-01-11 | FogPharma | 6 Dimensions Capital investment in Series C - FogPharma | 107 M USD |
2020-12-16 | Exo Therapeutics | 6 Dimensions Capital investment in Series A - Exo Therapeutics | 25 M USD |
2020-12-03 | MitrAssist | 6 Dimensions Capital investment in Venture Round - MitrAssist | 50 M USD |
2020-11-16 | Kira Pharmaceuticals | 6 Dimensions Capital investment in Venture Round - Kira Pharmaceuticals | N/A |
2020-05-08 | Haoxinqing | 6 Dimensions Capital investment in Series A - Haoxinqing | 125 M CNY |
2020-04-01 | ITeos Therapeutics | 6 Dimensions Capital investment in Series B - ITeos Therapeutics | 125 M USD |